"Kite Pharma Inc (KITE) Issues Earnings Results" was originally reported by Sports Perspectives and is owned by of Sports Perspectives. Receive News & Ratings for Kite Pharma Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kite Pharma Inc and related companies with MarketBeat.com's FREE daily email newsletter. Kite Pharma Company ProfileKite Pharma, Inc is a clinical-stage biopharmaceutical company. Kite Pharma Inc (NASDAQ:KITE) released its quarterly earnings results on Monday. Kite Pharma had a negative return on equity of 39.26% and a negative net margin of 994.89%.
"Kite Pharma Inc (KITE) Announces Quarterly Earnings Results, Beats Estimates By $0.44 EPS" was first published by Sports Perspectives and is owned by of Sports Perspectives. The firm's 50-day moving average price is $51.93 and its 200 day moving average price is $52.03. Kite Pharma Company ProfileKite Pharma, Inc is a clinical-stage biopharmaceutical company. Receive News & Ratings for Kite Pharma Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kite Pharma Inc and related companies with MarketBeat.com's FREE daily email newsletter. Kite Pharma had a negative return on equity of 39.26% and a negative net margin of 994.89%.
collected by :Lucy William
No comments:
Post a Comment